Close Menu

NEW YORK (GenomeWeb) – IBM said today that it plans to launch the first Watson Health European Center of Excellence in Milan, Italy in support of the government of Italy's initiative to establish an international hub for research in genomics, aging, nutrition, and other areas.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A former Centers for Disease Control and Prevention director calls on the current director, Robert Redfield, to address the agency's pandemic response shortcomings, USA Today reports.

Moderna has announced it will not enforce its COVID-19 vaccine-related patents during the pandemic, the Wall Street Journal reports.

Nature News reports that Australia's new budget includes AUS$1 billion in research funding to universities

In Science this week: analysis of mole genome sheds light on development of ovotestes.

Oct
21
Sponsored by
Roche

Target enrichment has been a major driver behind the clinical adoption of next-generation sequencing (NGS) over the last decade because it simplifies analysis and provides a cost-effective method of massive parallel resequencing. It has not only replaced Sanger sequencing, but it is actively dispensing the need for parallel copy number variant (CNV) analysis using classic techniques.

Oct
26
Sponsored by
Sophia Genetics

This webinar will discuss Genotypos Science Labs’ experience with a whole-exome sequencing solution supporting the detection of copy number variants (CNVs) for the management of complex cases.

Oct
27
Sponsored by
LGC SeraCare Life Sciences

This webinar brings together an expert panel of stakeholders in cancer diagnostics and clinical care who will discuss the promise and challenges of liquid biopsy technologies in cancer diagnosis, monitoring, and patient care management.

Oct
28
Sponsored by
NRGene

Molecular breeding methods such as genomic selection and genome-wide association studies often require high-density genotypic data from many samples, but the cost and complexity of genotyping at this scale may be prohibitive.